MedTrace Logo

Omnibond vs Dermabond

NCT05173519 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2024-02-07

No results posted yet for this study

Summary

This prospective, randomized, controlled, blinded clinical trial is designed to assess the incidence of all time and all types of wound-related complications following total joint arthroplasty (TJA) when two different types of topical skin adhesives are used to close the incision.

Conditions

Interventions

DEVICE

Omnibond Topical Skin Adhesive

Application of Omnibond topical skin adhesive to close incision following surgery

DEVICE

Dermabond Advanced Topical Skin Adhesive

Application of Dermabond topical skin adhesive to close incision following surgery

Sponsors & Collaborators

  • Center for Innovation and Research Organization

    lead NETWORK

Principal Investigators

  • Tiffany Morrison, MS · Center for Innovation and Research Organization

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-25
Primary Completion
2025-01-31
Completion
2025-02-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05173519 on ClinicalTrials.gov